Study | Reason for exclusion |
---|---|
Bui 2020 | Not an RCT |
Han 2020 | Not an RCT |
Huang 1988 | Quasi‐RCT. Randomized according to order of admission |
Huang 1989 | Quasi‐RCT. Odd and even numbers used for allocation |
Huang 1993 | RCT: conducted in people with complicated falciparum malaria |
Laman 2014 | Trial registration (ACTRN12610000913077) planned to use pyronaridine‐artesunate, but not available due to concerns over hepatotoxicity at time of trial. |
Leang 2016 | Not an RCT: single‐arm observational study |
Leang 2019a | Not an RCT |
Leang 2019b | Not an RCT |
Looareesuwan 1996 | Not an RCT: clinical trial of 2 doses of pyronaridine monotherapy, with group given second dose recruited after results of first dose were analysed |
Looareesuwan 2007 | RCT: phase II dose‐ranging trial |
Lutete 2021a | Not an RCT |
Piola 2008 | Not an RCT: phase II dose‐ranging study |
Ramharter 2008 | Not an RCT: open‐label dose‐escalation study |
Roth 2018b | Did not report our outcomes of interest |
Sagara 2014 | Not an RCT: pooled analysis |
Abbreviations: RCT: randomized controlled trial.